SRPT
Sarepta Therapeutics Inc
NASDAQ: SRPT · HEALTHCARE · BIOTECHNOLOGY
$20.67
-1.90% today
Updated 2026-04-29
Market cap
$2.18B
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$10 – $65
Volume
2.9M
Sarepta Therapeutics Inc (SRPT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-20.61M | $-24.68M | $-12.34M | $-8.80M | $-15.21M | $-23.68M | $-29.69M | $-64.69M | $-128.54M | $-149.47M | $-245.82M | $-232.00M | $-388.66M | $-456.46M | $107.47M | $-443.17M | $-325.35M | $-500.99M | $-205.79M | $-205.48M |
| Capital expenditures | $1.45M | $2.13M | $1.22M | $1.99M | $1.95M | $2.31M | $1.15M | $3.77M | $26.82M | $4.83M | $6.87M | $21.21M | $64.34M | $59.63M | $82.20M | $38.49M | $32.25M | $87.34M | $146.96M | $101.97M |
| Depreciation | $2.09M | $2.01M | $1.47M | $1.38M | $1.46M | $1.30M | $1.52M | $1.28M | $3.69M | $5.25M | $5.61M | $8.09M | $12.24M | $24.50M | $26.91M | $38.02M | $41.86M | $44.40M | $37.72M | — |
| Stock-based comp | $525126.00 | $312637.00 | $165882.00 | $2.37M | $3.17M | $3.13M | $3.08M | $11.13M | $20.34M | $32.12M | $29.96M | $30.46M | $50.13M | $78.60M | $108.07M | $113.94M | $233.02M | $182.51M | $184.30M | $123.40M |
| Free cash flow | $-22.07M | $-26.80M | $-13.56M | $-10.79M | $-17.16M | $-25.98M | $-30.84M | $-68.47M | $-155.36M | $-154.30M | $-252.69M | $-253.21M | $-453.00M | $-516.09M | $25.26M | $-481.66M | $-357.60M | $-588.34M | $-352.74M | $-307.45M |
| Investing cash flow | — | $10.58M | $-1.24M | $-1.88M | $-1.96M | $-2.31M | $-1.15M | $-11.67M | $-159.03M | $8.41M | $-90.19M | $-178.81M | $-370.49M | $286.73M | $-121.72M | $495.41M | $-1.05B | $-165.80M | $755.56M | — |
| Financing cash flow | $8.16M | $18.74M | $-31894.00 | $47.77M | $2.48M | $32.30M | $178.60M | $145.67M | $104.16M | $147.81M | $378.13M | $888.08M | $530.15M | $642.55M | $682.32M | $561.57M | $232.51M | $125.00M | $124.81M | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $240.60M | $286.31M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $6.32M | $147.76M | $69.30M | $-183.41M | $6.75M | $42.12M | $477.27M | $-229.00M | $472.82M | $668.07M | $613.81M | — | — | — | — |